share_log

BriaCell Therapeutics Shares Are Trading Higher After the Company Announced It Dosed the First Patient in Its Phase 1/2 Study of Bria-OTS.

BriaCell Therapeutics Shares Are Trading Higher After the Company Announced It Dosed the First Patient in Its Phase 1/2 Study of Bria-OTS.

BriaCell Therapeutics股價上漲,公司宣佈已在Bria-OTS的1/2期研究中給第一個患者投藥。
Benzinga ·  11:47

BriaCell Therapeutics Shares Are Trading Higher After the Company Announced It Dosed the First Patient in Its Phase 1/2 Study of Bria-OTS.

BriaCell Therapeutics宣佈在Bria-OTS的1/2期研究中爲第一位患者注射劑量後,該公司股價走高。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論